Jul 30, 2026
A U.S. federal judge ruled that Biden-era FDA restrictions on prescribing the abortion drug mifepristone are unlawful and unjustified, ordering the Trump Administration to reconsider existing regulations. The decision comes as over 400 state lawmakers from all 50 states have signed an amicus brief demanding protection for telehealth abortion care access.
Family planning and health organizations in Pennsylvania have filed a lawsuit alleging that a new Trump administration policy could delay or deny federal funding to providers serving tens of thousands of patients across the state.